695 related articles for article (PubMed ID: 33750405)
21. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs.
Reed MK; Guth A; Salcedo VJ; Hom JK; Rising KL
Int J Drug Policy; 2022 May; 103():103643. PubMed ID: 35255392
[TBL] [Abstract][Full Text] [Related]
22. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
[TBL] [Abstract][Full Text] [Related]
23. Pilot testing fentanyl test strip distribution in an emergency department setting: Experiences, lessons learned, and suggestions from staff.
Reed MK; Salcedo VJ; Hsiao T; Esteves Camacho T; Salvatore A; Siegler A; Rising KL
Acad Emerg Med; 2023 Jun; 30(6):626-635. PubMed ID: 36333960
[TBL] [Abstract][Full Text] [Related]
24. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
Barrolle AA; Gable KN; Dell N
J Am Pharm Assoc (2003); 2023; 63(1):295-300. PubMed ID: 36280433
[TBL] [Abstract][Full Text] [Related]
25. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants.
Reed MK; Roth AM; Tabb LP; Groves AK; Lankenau SE
Int J Drug Policy; 2021 Jun; 92():103147. PubMed ID: 33583679
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin.
Tilhou AS; Birstler J; Baltes A; Salisbury-Afshar E; Malicki J; Chen G; Brown R
Harm Reduct J; 2022 Dec; 19(1):142. PubMed ID: 36522777
[TBL] [Abstract][Full Text] [Related]
27. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
[TBL] [Abstract][Full Text] [Related]
28. High willingness to use rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL
Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052
[TBL] [Abstract][Full Text] [Related]
29. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study.
Park JN; Tomko C; Silberzahn BE; Haney K; Marshall BDL; Sherman SG
Addict Behav; 2020 Nov; 110():106529. PubMed ID: 32683172
[TBL] [Abstract][Full Text] [Related]
30. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
[TBL] [Abstract][Full Text] [Related]
31. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227
[No Abstract] [Full Text] [Related]
32. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
[TBL] [Abstract][Full Text] [Related]
33. Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016.
Park JN; Rashidi E; Foti K; Zoorob M; Sherman S; Alexander GC
Drug Alcohol Depend; 2021 Jan; 218():108416. PubMed ID: 33278761
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
[TBL] [Abstract][Full Text] [Related]
35. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America.
Lieberman M; Badea A; Desnoyers C; Hayes K; Park JN
Harm Reduct J; 2024 Jun; 21(1):115. PubMed ID: 38877522
[TBL] [Abstract][Full Text] [Related]
36. Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance.
Shover CL; Falasinnu TO; Dwyer CL; Santos NB; Cunningham NJ; Freedman RB; Vest NA; Humphreys K
Drug Alcohol Depend; 2020 Nov; 216():108314. PubMed ID: 33038637
[TBL] [Abstract][Full Text] [Related]
37. Perspectives on Fentanyl Test Strip Use among People Who Inject Drugs in Rural Appalachia.
Allen ST; O'Rourke A; White RH; Sherman SG; Grieb SM
Subst Use Misuse; 2020; 55(10):1594-1600. PubMed ID: 32336188
[No Abstract] [Full Text] [Related]
38. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Ciccarone D
Curr Opin Psychiatry; 2021 Jul; 34(4):344-350. PubMed ID: 33965972
[TBL] [Abstract][Full Text] [Related]
39. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
[TBL] [Abstract][Full Text] [Related]
40. Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS/MS) in illicit drug samples collected in Chicago, IL.
Whitehead HD; Hayes KL; Swartz JA; Prete E; Robison-Taylor L; Mackesy-Amiti ME; Jimenez AD; Lieberman M
Forensic Chem; 2023 May; 33():. PubMed ID: 36910306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
